Hyaluronic acid as a treatment for ankle osteoarthritis

被引：43

作者：

Sun S.-F. ^{[1
,2
]}

Chou Y.-J. ^{[3
]}

Hsu C.-W. ^{[4
]}

Chen W.-L. ^{[1
]}

机构：

[1] Department of Physical Medicine and Rehabilitation, Veterans General Hospital, Kaohsiung, Kaohsiung 813, No 386

[2] National Yang-Ming University, School of Medicine, Taipei

[3] Department of Orthopedic Surgery, Veterans General Hospital, Kaohsiung, Kaohsiung

[4] Department of Internal Medicine, Veterans General Hospital, Kaohsiung

来源：

Current Reviews in Musculoskeletal Medicine | 2009年 / 2卷 / 2期

关键词：

Ankle joint; Hyaluronic acid; Osteoarthritis; Viscosupplementation;

D O I：

10.1007/s12178-009-9048-5

中图分类号：

学科分类号：

摘要：

Viscosupplementation refers to the concept of synovial fluid replacement with intra-articular injections of hyaluronic acid (HA) for the relief of pain associated with osteoarthritis (OA). Intra-articular viscosupplementation was approved by the Food and Drug Administration (FDA) in 1997. It is currently indicated only for the treatment of pain associated with knee OA. However, OA can occur in several of the weight-bearing joints of the foot and ankle. Ankle OA produces chronic disability that directly impacts the quality of life. There is only limited published literature relating to the use of HA in the ankle. This paper will review the authors' experience, indications, clinical outcomes, and complications of viscosupplementation therapy in patients with ankle OA.

引用

页码：78 / 82

页数：4

共 34 条

[1]

Creamer P., Hochberg M.C., Osteoarthritis, Lancet, 350, pp. 503-508, (1997)

[2]

Felson D.T., Lawrence R.C., Dieppe P.A., Hirsch R., Helmick C.G., Jordan J.M., Kington R.S., Lane N.E., Nevitt M.C., Zhang Y., Sowers M., McAlindon T., Spector T.D., Poole A.R., Yanovski S.Z., Ateshian G., Sharma L., Buckwalter J.A., Brandt K.D., Fries J.F., Osteoarthritis: New insights - Part 1: The disease and its risk factors, Annals of Internal Medicine, 133, 8, pp. 635-646, (2000)

[3]

Buckwalter J.A., Mankin H.J., Articular cartilage: Degeneration and osteoarthritis, repair, regeneration, and transplantation, Instr Course Lect, 47, pp. 487-504, (1998)

[4]

Adams M.E., An analysis of clinical studies of the use of crosslinked hyaluronan, hylan, in the treatment of osteoarthritis, Journal of Rheumatology, 20, SUPPL. 39, pp. 16-18, (1993)

[5]

Frizziero L., Govoni E., Bacchini P., Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: Clinical and morphological study, Clinical and Experimental Rheumatology, 16, 4, pp. 441-449, (1998)

[6]

Adams M.E., Atkinson M.H., Lussier A.J., Schulz J., Siminovitch K.A., Wade J.P., Zummer M., The role of viscosupplementation with hylan G-F 20 (Synvisc®) in the treatment of osteoarthritis of the knee: A Canadian multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone, Osteoarthritis and Cartilage, 3, 4, pp. 213-225, (1995)

[7]

Belcher C., Yaqub R., Fawthrop F., Bayliss M., Doherty M., Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees, Annals of the Rheumatic Diseases, 56, 5, pp. 299-307, (1997)

[8]

Engstrom-Laurent A., Hyaluronan in joint disease, Journal of Internal Medicine, 242, 1, pp. 57-60, (1997)

[9]

Balazs E.A., Denlinger J.L., Viscosupplementation: A new concept in the treatment of osteoarthritis, J Rheumatol Suppl, 39, pp. 4-9, (1993)

[10]

Rydell N., Balazs E.A., Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation, Clin Orthop, 80, pp. 25-32, (1971)

← 1 2 3 4 →